Feb 17, 2025
Confidence A
Abridge capital or status signal reviewed
FundingAbridge public source reviewed for capital or strategic-status timeline signal.
AA
Enterprise AIConfidence BUnited States
Abridge
Clinical AI platform that converts medical conversations into structured documentation.
Status timeline
Funding, product, customer, team, and risk signalsFeb 17, 2025
Confidence A
Abridge product scope reviewed
ProductAbridge public product source reviewed for category placement and current operating focus.
Funding timeline
Amounts are shown only when disclosed by evidence.
| Company | Round | Amount | Investors | Date | Evidence | Open |
|---|---|---|---|---|---|---|
| AAAbridgeabridge.com | Series D+ | Undisclosed | IVP, Lightspeed | Feb 17, 2025 | Confidence A |
Editor observation
Abridge is worth monitoring for product traction, durable distribution, and evidence-backed status changes in its category.
Public-source facts can change quickly; Alynt should re-check operating status, financing status, and source permissions before each weekly release.